AI Platform Visualization

Core Technology Platform

AI-driven Innovative Drug Discovery Platform

Proprietary LLM-based platform integrating Transformer technology and a database of 22M+ small molecule compounds, supporting classification training for 50,000+ biological targets.

Learn more
Core Technological Advantages

Core Technological Advantages and Innovations

Four Core Innovations Empowering AI Drug Discovery

Explore our four core technological innovations in AI-driven drug discovery, including AI molecule generation, AI+quantum simulation, automated closed-loop optimization, and LLM-powered chemical reasoning.

Learn more
Competitive Barriers and Advantages

Breakthrough Case Studies

Genion's AI-driven platform, leveraging advanced Graph Neural Networks (GNN) and quantum simulations, has achieved breakthroughs in multiple therapeutic areas, including cancer, neurodegenerative diseases, infectious diseases, and autoimmune diseases. These innovations have significantly enhanced drug discovery and optimization.

Cancer research visualization

Cancer Drugs

AI-driven EGFR inhibitor development with exceptional anti-tumor effects.

Read case study
Neurodegenerative disease research

Neurodegenerative Diseases

Blood-brain barrier penetrating compounds targeting protein aggregation in Alzheimer's disease.

Read case study
Infectious disease research

Infectious Diseases

AI-powered screening of novel antibiotics and antivirals with high selectivity.

Read case study
Autoimmune disease research

Autoimmune Diseases

Next-generation immunomodulatory drugs with strong efficacy and minimal side effects.

Read case study